Strides Pharma Science gets FDA approval for Fluoxetine Tablets for depressive disorders

Pallavi Madhiraju- April 9, 2024 0

Strides Pharma Science Limited (Strides) has made a notable advancement in the field of mental health treatment by securing approval from the United States Food ... Read More

Strides Pharma Science receives FDA approval for Pregabalin capsules

Pallavi Madhiraju- January 25, 2024 0

Strides Pharma Science Limited (Strides) has achieved a significant milestone in the pharmaceutical industry with the United States Food & Drug Administration (USFDA) approval of ... Read More

Strides Pharma, Amneal Pharmaceuticals partner to launch Icosapent ethyl capsules

Pallavi Madhiraju- December 2, 2023 0

Strides Pharma Science Limited (“Strides”) has joined forces with Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal”) to introduce Icosapent ethyl acid soft gel capsules to the ... Read More

Strides Pharma subsidiary receives FDA approval for bowel prep solution

Pallavi Madhiraju- November 23, 2023 0

Strides Pharma Science Limited, through its subsidiary Strides Pharma Global Pte. Limited, Singapore, has recently achieved a significant milestone by receiving approval from the United ... Read More

Strides Pharma subsidiary gains FDA approval for EET tablets

Pallavi Madhiraju- October 5, 2023 0

Strides Pharma Science Limited has announced a significant achievement, with its wholly-owned subsidiary, Strides Pharma Global Pte. Limited in Singapore, receiving approval from the United ... Read More

Strides Pharma’s HIV generic drug gets tentative FDA approval

Pallavi Madhiraju- September 14, 2023 0

Strides Pharma Science Limited (Strides) announced that its Singapore-based stepdown wholly owned subsidiary, Strides Pharma Global Pte. Limited, has received tentative approval for Dolutegravir 50mg ... Read More

Strides Pharma wins FDA approval for kidney drug Sevelamer Carbonate

Pallavi Madhiraju- September 10, 2023 0

In a major coup for Strides Pharma Science Limited, the company's stepdown wholly-owned subsidiary, Strides Pharma Global Pte. Limited in Singapore, has scored approval from ... Read More

Strides Pharma gets FDA nod for Mycophenolate Mofetil, targets $145m market

Pallavi Madhiraju- August 30, 2023 0

Strides Pharma Science Limited has announced a significant win as its Singapore-based wholly owned subsidiary, Strides Pharma Global Pte. Limited, has received United States Food ... Read More

Strides Pharma Science’s CDMO unit gets FDA EIR for Bengaluru facility

Pallavi Madhiraju- January 18, 2023 0

Strides Pharma Science said that its biologics arm Stelis Biopharma has secured an establishment inspection report (EIR) from the US Food and Drug Administration (FDA) ... Read More

Strides Pharma gets FDA approval for Potassium Chloride Oral Solution generic

Pallavi Madhiraju- November 20, 2022 0

Strides Pharma Science has secured approval for Potassium Chloride Oral Solution USP, 40 mEq/15mL (20%) from the US Food & Drug Administration (FDA). The approval ... Read More